Colony Bankcorp Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

Colony Bankcorp hat eine Bilanzsumme von $3.0B und ein Eigenkapital von $259.9M. Die Gesamteinlagen belaufen sich auf $2.5B, die Gesamtkredite auf $1.8B. Das Unternehmen erzielt eine Nettozinsmarge von 2.8%. Es verfügt über ausreichende Wertberichtigungen für notleidende Kredite, die derzeit 0.3% der gesamten Kredite betragen. Die Barmittel und kurzfristigen Anlagen betragen $95.0M.

Wichtige Informationen

11.6x

Verhältnis von Vermögen zu Eigenkapital

2.8%

Nettozinsspanne

Gesamteinlagen	US$2.52b
Kredit- zu Einlagenverhältnis	Angemessen
Notleidende Kredite	0.3%
Wertberichtigung für notleidende Kredite	Ausreichend
Liquiditätskennzahl	Niedrig
Bargeld und Äquivalente	US$95.03m

Jüngste Berichte zur Finanzlage

Keine Aktualisierungen

Recent updates

Colony Bankcorp's (NASDAQ:CBAN) Upcoming Dividend Will Be Larger Than Last Year's

Jan 28

Colony Bankcorp Non-GAAP EPS of $0.30 misses by $0.07, revenue of $29.04M misses by $2.73M

Oct 20

Colony Bankcorp goes ex-dividend tomorrow

Aug 03

Colony Bankcorp (NASDAQ:CBAN) Has Affirmed Its Dividend Of $0.1075

Jul 29

Colony Bankcorp GAAP EPS of $0.19, revenue of $29.4M

Jul 21

Colony Bankcorp (NASDAQ:CBAN) Is Due To Pay A Dividend Of US$0.11

May 02

Earnings Miss: Colony Bankcorp, Inc. Missed EPS By 11% And Analysts Are Revising Their Forecasts

Apr 23

Colony Bankcorp's (NASDAQ:CBAN) Dividend Will Be Increased To US$0.11

Jan 24

Colony Bankcorp (NASDAQ:CBAN) Will Pay A Dividend Of US$0.10

Oct 25

Colony Bankcorp (NASDAQ:CBAN) Has Announced A Dividend Of US$0.10

Jul 26

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz

Analyse der Finanzinstitute

Vermögensebene: CBANDas Verhältnis von Vermögen zu Eigenkapital (11.6x) ist moderat.

Wertberichtigung für uneinbringliche Kredite: CBAN hat eine ausreichende Wertberichtigung für notleidende Kredite (290%).

Verbindlichkeiten mit geringem Risiko: 92% der Verbindlichkeiten von CBAN bestehen hauptsächlich aus risikoarmen Finanzierungsquellen.

Darlehenshöhe: CBAN ein angemessenes Niveau des Verhältnis von Krediten zu Vermögenswerten aufweist (61%).

Einlagen mit geringem Risiko: CBANDas Verhältnis von Krediten zu Einlagen (73%) ist angemessen.

Höhe der notleidenden Kredite: CBAN einen angemessenen Anteil an notleidenden Krediten hat (0.3%).

Colony Bankcorp Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Recent updates

Price target decreased by 8.6% to US$13.25

First quarter dividend of US$0.11 announced

Colony Bankcorp, Inc. Reports Net Loan Charge-Offs Results for the First Quarter Ended March 31, 2024

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Colony Bankcorp, Inc. Declares Quarterly Cash Dividend, Payable on May 22, 2024

Colony Bankcorp, Inc., Annual General Meeting, May 16, 2024

Colony Bankcorp, Inc. to Report Q1, 2024 Results on Apr 24, 2024

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Upcoming dividend of US$0.11 per share at 3.5% yield

Colony Bankcorp's (NASDAQ:CBAN) Upcoming Dividend Will Be Larger Than Last Year's

Fourth quarter dividend increased to US$0.11

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Colony Bankcorp, Inc. Reports Net Loans Charged-Off for the Fourth Quarter of 2023

Colony Bankcorp, Inc. Announces Promotion of Derek Shelnutt to Executive Vice President

Colony Bankcorp, Inc. to Report Q4, 2023 Results on Jan 24, 2024

Price target increased by 7.1% to US$13.83

Independent Director recently sold US$311k worth of stock

Harold W. Wyatt, Iii, Member of the Board of Directors of Colony Bankcorp, Inc. and Colony Bank Provides Notice of His Decision Not to Stand for Reelection

Independent Director recently sold US$211k worth of stock

New minor risk - Insider selling

Independent Director recently sold US$117k worth of stock

Upcoming dividend of US$0.11 per share at 4.5% yield

Colony Bankcorp (NASDAQ:CBAN) Is Due To Pay A Dividend Of $0.11

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Colony Bankcorp, Inc. Declares Quarterly Cash Dividend, Payable on November 22, 2023

Colony Bankcorp, Inc. to Report Q3, 2023 Results on Oct 25, 2023

Colony Bankcorp, Inc. Announces Retirement of Brian D. Schmitt as Executive Vice Chairman

Upcoming dividend of US$0.11 per share at 4.1% yield

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Colony Bankcorp Reports Net Loan Charge-Offs for the Second Quarter Ended June 30, 2023

Colony Bankcorp, Inc. to Report Q2, 2023 Results on Jul 26, 2023

Upcoming dividend of US$0.11 per share at 4.9% yield

Price target decreased by 8.6% to US$13.33

Full year 2022 earnings: EPS misses analyst expectations

Price target decreased by 8.4% to US$14.58

Consensus EPS estimates fall by 14%

Colony Bankcorp (NASDAQ:CBAN) Has Announced A Dividend Of $0.11

Full year 2022 earnings: EPS misses analyst expectations

Colony Bankcorp, Inc. to Report Q4, 2022 Results on Jan 26, 2023

Executive VP & Chief of Staff recently bought US$53k worth of stock

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Colony Bankcorp, Inc. Announces Edward G. “Ed” Canup as Chief Revenue Officer and President of Banking Solutions

Consensus EPS estimates fall by 10%

Upcoming dividend of US$0.11 per share

Colony Bankcorp Appoints Audrey Hollingsworth to Board of Directors

Colony Bankcorp's (NASDAQ:CBAN) Dividend Will Be $0.1075

Colony Bankcorp, Inc. (NasdaqGM:CBAN) announces an Equity Buyback for $12 million worth of its shares.

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Colony Bankcorp, Inc. Declares Quarterly Cash Dividend, Payable on November 18, 2022

Colony Bankcorp Non-GAAP EPS of $0.30 misses by $0.07, revenue of $29.04M misses by $2.73M

Colony Bankcorp, Inc. to Report Q3, 2022 Results on Oct 20, 2022

Colony Bank Promotes Laurie Senn as Executive to Chief Operations Officer

Colony Bankcorp, Inc. Announces Executive Changes

Colony Bankcorp goes ex-dividend tomorrow

Colony Bankcorp (NASDAQ:CBAN) Has Affirmed Its Dividend Of $0.1075

Consensus forecasts updated

Price target decreased to US$18.33

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Colony Bankcorp, Inc. Reports Net Loans Charged-Off for the Second Quarter Ended June 30, 2022

Colony Bankcorp GAAP EPS of $0.19, revenue of $29.4M

Independent Director recently bought US$190k worth of stock

Colony Bankcorp (NASDAQ:CBAN) Is Due To Pay A Dividend Of US$0.11

Upcoming dividend of US$0.11 per share

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Earnings Miss: Colony Bankcorp, Inc. Missed EPS By 11% And Analysts Are Revising Their Forecasts

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Colony Bankcorp, Inc. Declares Quarterly Cash Dividend for the First Quarter Ended March 31, 2022, Payable on May 20, 2022

Colony Bankcorp, Inc. Appoints Andrew Borrmann as Chief Financial Officer

Colony Bankcorp, Inc. Announces CFO Changes

Colony Bankcorp, Inc., Annual General Meeting, May 19, 2022

Consensus forecasts updated

Colony Bankcorp, Inc. has completed a Follow-on Equity Offering in the amount of $55.217399 million.

Colony Bankcorp, Inc. has completed a Follow-on Equity Offering in the amount of $55.217399 million.

Upcoming dividend of US$0.11 per share

Colony Bankcorp's (NASDAQ:CBAN) Dividend Will Be Increased To US$0.11